Sign in
4/A

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040296

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Heffernan Michael Thomas · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-23 Grant or award : show line 1 in the form Nonstatutory Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X03/doc4a.xml…